Fortress Biotech (FBIO) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to -$76.9 million.
- Fortress Biotech's Enterprise Value rose 1709.34% to -$76.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$76.9 million, marking a year-over-year increase of 1709.34%. This contributed to the annual value of -$81.6 million for FY2024, which is 1986.57% up from last year.
- Per Fortress Biotech's latest filing, its Enterprise Value stood at -$76.9 million for Q3 2025, which was up 1709.34% from -$80.9 million recorded in Q2 2025.
- Over the past 5 years, Fortress Biotech's Enterprise Value peaked at -$76.9 million during Q3 2025, and registered a low of -$191.8 million during Q1 2022.
- Its 5-year average for Enterprise Value is -$128.2 million, with a median of -$112.5 million in 2023.
- As far as peak fluctuations go, Fortress Biotech's Enterprise Value crashed by 5484.75% in 2021, and later surged by 4005.48% in 2023.
- Fortress Biotech's Enterprise Value (Quarter) stood at -$188.5 million in 2021, then increased by 9.85% to -$170.0 million in 2022, then skyrocketed by 40.05% to -$101.9 million in 2023, then rose by 19.87% to -$81.6 million in 2024, then increased by 5.82% to -$76.9 million in 2025.
- Its Enterprise Value was -$76.9 million in Q3 2025, compared to -$80.9 million in Q2 2025 and -$81.1 million in Q1 2025.